ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Authorization Bills Require NCI To Spend 10% On Cancer control

February 12, 1993

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

July 6, 1990

FDA Proposes Guidelines For Testing New Anticancer Drugs

November 14, 1975

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

Finasteride Raises Odds Of Finding Fast-Growing Cancers Early, Study Says

September 28, 2007

Saffiotti Couldn’t Cope With Demands Of National Program, Rauscher Says In Letter To Kennedy

June 11, 1976